The company has successfully developed Methyl salicylate using Flow Chemistry and successfully erected a Flow reactor at Jhagadia plant and expects to start production from Q3 FY23
Ketorolac Tromethamine is advised for the short-term management of moderately severe acute pain in adult patients
API platform to comprise of RA Chem Pharma, ZCL Chemicals and Avra Laboratories
This is the first injectable product approval from our General Sterile Facility (F-3) which was inspected in August, 2022.
The company currently supplies one product to the US market that contributes low- single digit revenue to Jubilant Pharmova revenue
Frazier led the company for 10 years as President and Chief Executive Officer, from 2011 through 2021.
Submission based on QuANTUM-First results showing quizartinib plus chemotherapy significantly improved overall survival compared to chemotherapy alone
Esiloc was launched at the biggest doctor engagement webinar involving more than 12,000 doctors across the country
He also highlighted the need for community awareness for continued implementation of the Covid Appropriate Behaviour (CAB) especially in view of the upcoming festival season
ADCelerate delivers Phase I appropriate antibody-drug conjugate (ADC) drug substance and drug product for Investigational New Drug (IND) submission
Subscribe To Our Newsletter & Stay Updated
